VANCOUVER, Wash. and NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences.
- H.C. Wainwright 25th Annual Global Investment Conference
Fireside chat on Monday, September 11th at 2:00 p.m. Eastern Time
- Morgan Stanley 21st Annual Global Healthcare Conference
Fireside chat on Wednesday, September 13th at 4:55 p.m. Eastern Time
- 2023 Cantor Fitzgerald Global Healthcare Conference
Fireside chat on Tuesday, September 26th at 8:10 a.m. Eastern Time
Interested parties may access live and archived webcasts of these events on the company's investor relations website at: investors.absci.com.
About Absci
Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies ...